← SynDRA
LY-255283
SynDRA canonical compound SYN0000826 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | LTB4R | LTB4R2 |
|---|
| Mechanism of action | leukotriene receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- LTB4R INHIBITOR
- LTB4R2 INHIBITOR
Drug classes
Cross-references
Synonyms
- GTPL3351
- MolPort-009-018-745
- HMS3649C08
- ZINC27644044
- SR-01000946596
- SR-01000946596-1
- LY255283
- LY 255283
- H037W1I5AL
- CGS-23356
- RefChem:154506
- DTXCID3074363
- LY255283;LY-255283;CGS 23356
- UNII-H037W1I5AL
- orb1305772
- SCHEMBL4562255
- SCHEMBL7749547
- BDBM81519
- CHEBI:93616
- HMS3268D04
- HMS3413M21
- HMS3677M21
- SEA69079
- BDBM50212626
- MFCD00876422
- s2959
- AKOS022180215
- NCGC00092338-01
- DA-75186
- HY-15744
- MS-25707
- CAS_117690-79-6
- CS-0008561
- LY255283, >=98% (HPLC), powder
- E76686
- T22946
- F869948
- L002034
- BRD-K92492521-001-01-1
Look up LY-255283 in the interactive SynDRA portal →